BioSig Technologies, Inc. STEX Change In Fair Value Of Convertible Debenture Embedded Derivative

Change In Fair Value Of Convertible Debenture Embedded Derivative at other companies

Lucid DiagnosticsLUCD

-$1.86M+87.2%

PTH

Pelthos Therapeutics Inc.PTHS

$5.2M—

Lucid DiagnosticsLUCD

-$1.86M+87.2%

Beyond MeatBYND

$11.89M—

Douglas EllimanDOUG

$0+100%

GCT

GCT Semiconductor HoldingGCTS

-$1.29M-6,668%

Other financials

Income statement

See full

Revenue$13.0K+8.3%

Gross profit$12.0K-88.9%

Operating income-$35.7M-1,098%

Net income-$46.7M-1,560%

EPS (diluted)-$0.27-92.9%

Balance sheet

See full

Cash & equivalents$6.9M+84.0%

Total debt$15.0K-94.7%

Total equity$159.0M+6,003%

Total assets$173.3M+3,823%

Cash flow

See full

Operating cash flow-$10.2M-813%

CapEx$4.0K-93.1%

Free cash flow-$2.9M+29.4%

Valuation

See full

Market cap$88.66M-56.4%

P/S2,216.6×-5,967×

Profitability

See full

Gross margin80.1%+25.2pp

Operating margin-32,155%-14,261pp

Net margin-25,825%-11,789pp

FCF margin-97,216.7%-106,293pp

Returns & leverage

See full

Return on equity-627.1%—

Debt / equity0×—

Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept STEX:ChangeInFairValueOfConvertibleDebentureEmbeddedDerivative.

The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s change in fair value of convertible debenture embedded derivative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioSig Technologies, Inc.'s change in fair value of convertible debenture embedded derivative?: BioSig Technologies, Inc. (STEX) reported change in fair value of convertible debenture embedded derivative of -$1.75M in Q4 2025.
What does change in fair value of convertible debenture embedded derivative mean?: Captures the non-cash impact of changes in the fair value of embedded derivatives within convertible debt instruments. This metric highlights the accounting volatility introduced by the conversion features of debt, which are marked-to-market each period. It helps analysts distinguish between core business cash flows and accounting adjustments related to financing arrangements.